skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:064207/0957   Pages: 16
Recorded: 07/06/2023
Conveyance: SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 125
Page 2 of 2
Pages: 1 2
1
Patent #:
11739071
Issue Dt:
08/29/2023
Application #:
17096349
Filing Dt:
11/12/2020
Publication #:
US20210130321
Pub Dt:
05/06/2021
Title:
QUINAZOLINONES AND AZAQUINAZOLINONES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS
2
Patent #:
11919891
Issue Dt:
03/05/2024
Application #:
17121165
Filing Dt:
12/14/2020
Publication #:
US20210347768
Pub Dt:
11/11/2021
Title:
BICYCLIC COMPOUNDS USEFUL AS GPR120 MODULATORS
3
Patent #:
11702412
Issue Dt:
07/18/2023
Application #:
17124778
Filing Dt:
12/17/2020
Publication #:
US20210206755
Pub Dt:
07/08/2021
Title:
BICYCLIC [4,6,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
4
Patent #:
11730721
Issue Dt:
08/22/2023
Application #:
17130704
Filing Dt:
12/22/2020
Publication #:
US20210186940
Pub Dt:
06/24/2021
Title:
2-SPIRO-5- AND 6-HYDROXAMIC ACID INDANES AS HDAC INHIBITORS
5
Patent #:
NONE
Issue Dt:
Application #:
17161324
Filing Dt:
01/28/2021
Publication #:
US20210292337
Pub Dt:
09/23/2021
Title:
THIENOPYRIMIDINONES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS
6
Patent #:
NONE
Issue Dt:
Application #:
17179046
Filing Dt:
02/18/2021
Publication #:
US20210323978
Pub Dt:
10/21/2021
Title:
ISOTHIAZOLOPYRIMIDINONES, PYRAZOLOPYRIMIDINONES, AND PYRROLOPYRIMIDINONES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS
7
Patent #:
NONE
Issue Dt:
Application #:
17186915
Filing Dt:
02/26/2021
Publication #:
US20210332052
Pub Dt:
10/28/2021
Title:
PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS
8
Patent #:
11795171
Issue Dt:
10/24/2023
Application #:
17230603
Filing Dt:
04/14/2021
Publication #:
US20220033403
Pub Dt:
02/03/2022
Title:
PYRROLOTRIAZINONES AND IMIDAZOTRIAZINONES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS
9
Patent #:
11891365
Issue Dt:
02/06/2024
Application #:
17238321
Filing Dt:
04/23/2021
Publication #:
US20220363651
Pub Dt:
11/17/2022
Title:
3-ALKYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
10
Patent #:
11919839
Issue Dt:
03/05/2024
Application #:
17238529
Filing Dt:
04/23/2021
Publication #:
US20220073452
Pub Dt:
03/10/2022
Title:
ALPHA-CINNAMIDE COMPOUNDS AND COMPOSITIONS AS HDAC8 INHIBITORS
11
Patent #:
NONE
Issue Dt:
Application #:
17265883
Filing Dt:
02/04/2021
Publication #:
US20210179628
Pub Dt:
06/17/2021
PCT #:
US2019045734
Title:
INHIBITING DEUBIQUITINASE USP25 AND USP28
12
Patent #:
NONE
Issue Dt:
Application #:
17266026
Filing Dt:
02/04/2021
Publication #:
US20210323975
Pub Dt:
10/21/2021
PCT #:
US2019045732
Title:
CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS
13
Patent #:
NONE
Issue Dt:
Application #:
17431664
Filing Dt:
08/17/2021
Publication #:
US20230002450
Pub Dt:
01/05/2023
PCT #:
US2020018680
Title:
Bispecific Fusion Protein Using Orthopoxvirus Major Histocompatibility Complex (MHC) Class I-Like Protein (OMCP) and Tumor-Specific Binding Partner
14
Patent #:
NONE
Issue Dt:
Application #:
17607595
Filing Dt:
10/29/2021
Publication #:
US20220213088
Pub Dt:
07/07/2022
PCT #:
US2020030833
Title:
INHIBITING USP36
15
Patent #:
NONE
Issue Dt:
Application #:
17608392
Filing Dt:
11/02/2021
Publication #:
US20220204495
Pub Dt:
06/30/2022
PCT #:
US2020031214
Title:
INHIBITING TRABID
16
Patent #:
NONE
Issue Dt:
Application #:
17609105
Filing Dt:
11/05/2021
Publication #:
US20220213059
Pub Dt:
07/07/2022
PCT #:
US2020031608
Title:
INHIBITING USP19
17
Patent #:
NONE
Issue Dt:
Application #:
17691186
Filing Dt:
03/10/2022
Publication #:
US20220204461
Pub Dt:
06/30/2022
Title:
3-ARYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
18
Patent #:
NONE
Issue Dt:
Application #:
17712001
Filing Dt:
04/01/2022
Publication #:
US20220235018
Pub Dt:
07/28/2022
Title:
METHODS USING HDAC11 INHIBITORS
19
Patent #:
NONE
Issue Dt:
Application #:
17798048
Filing Dt:
08/05/2022
Publication #:
US20230113389
Pub Dt:
04/13/2023
PCT #:
US2021016317
Title:
INTEGRATED SYSTEM FOR 3D TISSUE CULTURE
20
Patent #:
NONE
Issue Dt:
Application #:
17941061
Filing Dt:
09/09/2022
Publication #:
US20230110003
Pub Dt:
04/13/2023
Title:
PIPERIDINE DERIVATIVES AND COMPOSITIONS FOR THE INHIBITION OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT)
21
Patent #:
NONE
Issue Dt:
Application #:
17959064
Filing Dt:
10/03/2022
Publication #:
US20230183231
Pub Dt:
06/15/2023
Title:
MONOCYCLIC COMPOUNDS USEFUL AS GPR120 MODULATORS
22
Patent #:
NONE
Issue Dt:
Application #:
17984065
Filing Dt:
11/09/2022
Publication #:
US20230242512
Pub Dt:
08/03/2023
Title:
ISOINDOLINES AS HDAC INHIBITORS
23
Patent #:
NONE
Issue Dt:
Application #:
18073768
Filing Dt:
12/02/2022
Publication #:
US20230346753
Pub Dt:
11/02/2023
Title:
NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT
24
Patent #:
NONE
Issue Dt:
Application #:
18096712
Filing Dt:
01/13/2023
Publication #:
US20230406830
Pub Dt:
12/21/2023
Title:
[6,6] FUSED BICYCLIC HDAC8 INHIBITORS
25
Patent #:
NONE
Issue Dt:
Application #:
18196459
Filing Dt:
05/12/2023
Publication #:
US20230357216
Pub Dt:
11/09/2023
Title:
BICYCLIC [4,6,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
Assignors
1
VALO HEALTH, LLC
Exec Dt:
06/30/2023
2
VALO HEALTH, INC.
Exec Dt:
06/30/2023
Assignee
1
FIRST-CITIZENS BANK & TRUST COMPANY, AS AGENT
505 HOWARD STREET
FLOOR 3
SAN FRANCISCO, CALIFORNIA 94105
Correspondence name and address
DLA PIPER LLP (US)
4365 EXECUTIVE DRIVE
SUITE 1100
SAN DIEGO, CA 92121

Search Results as of: 05/28/2024 12:07 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT